An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin

By Goel R.   Chouinard E.   Stewart D. J.   Huan S.   Hirte H.   Stafford S.   Waterfield B.   Roach J.   Lathia C.   Agarwal V.   Humphrey R.   Walsh W.   Matthews S.   Seymour L.  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 63-71

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

By Kang Byung  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1671-1675

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin, fluorouracil, docetaxel in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

By Tsavaris Nicolas   Kosmas Christos   Skopelitis Helias   Gouveris Panagiotis   Kopteridis Petros   Loukeris Dioynissis   Sigala Frantzeska   Zorbala-Sypsa Alexandra   Felekouras Evangelos   Papalambros Efstathios  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite